A Safety News article.
As the world pins its hopes on Pfizer’s announcement this week of an effective vaccine, Macquarie University researchers have unveiled a strategy addressing the question of who should be vaccinated first.
With thousands of scientists around the world racing to develop a vaccine for COVID-19, policy makers may need to decide who is at the front of the vaccination queue if initial supplies are limited.
Such decisions loom closer as drug giant Pfizer announces a vaccine that is 90 per cent effective in people not previously infected with the virus, and researchers at Macquarie University, QUT and Australia’s national agency CSIRO may have a solution once a vaccine is ready.
To read more, click here.